Technical Analysis for ARMP - Armata Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Signal Line Cross | Bearish | 0.00% | |
20 DMA Support | Bullish | 0.00% | |
NR7 | Range Contraction | -4.90% | |
NR7-2 | Range Contraction | -4.90% | |
Narrow Range Bar | Range Contraction | -4.90% | |
Wide Bands | Range Expansion | -4.90% | |
NR7 | Range Contraction | -9.33% | |
NR7-2 | Range Contraction | -9.33% | |
Wide Bands | Range Expansion | -9.33% | |
Gapped Up | Strength | -9.33% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Down 5% | 25 days ago |
Down 3% | 25 days ago |
Fell Below Previous Day's Low | 25 days ago |
Down 2 % | 25 days ago |
Down 1% | 25 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/15/2023
Armata is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Armata's lead product candidate, AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. The Company is also developing and advancing a broad pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa, leveraging its proprietary phage-specific GMP manufacturing capabilities.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Antibiotics Bacteria Staphylococcus Aureus Pathogenic Bacteria Pseudomonas Bacteriophage Drug Resistance Gram Negative Bacteria Pseudomonas Aeruginosa Manufacturing Capabilities Multiple Drug Resistance
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Antibiotics Bacteria Staphylococcus Aureus Pathogenic Bacteria Pseudomonas Bacteriophage Drug Resistance Gram Negative Bacteria Pseudomonas Aeruginosa Manufacturing Capabilities Multiple Drug Resistance
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.7864 |
52 Week Low | 0.8311 |
Average Volume | 24,842 |
200-Day Moving Average | 3.43 |
50-Day Moving Average | 2.07 |
20-Day Moving Average | 2.67 |
10-Day Moving Average | 3.09 |
Average True Range | 0.31 |
RSI | 53.70 |
ADX | 30.11 |
+DI | 31.48 |
-DI | 25.09 |
Chandelier Exit (Long, 3 ATRs) | 2.83 |
Chandelier Exit (Short, 3 ATRs) | 2.28 |
Upper Bollinger Bands | 3.74 |
Lower Bollinger Band | 1.59 |
Percent B (%b) | 0.52 |
BandWidth | 80.69 |
MACD Line | 0.28 |
MACD Signal Line | 0.31 |
MACD Histogram | -0.0256 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.20 | ||||
Resistance 3 (R3) | 3.22 | 3.08 | 3.12 | ||
Resistance 2 (R2) | 3.08 | 2.96 | 3.07 | 3.09 | |
Resistance 1 (R1) | 2.90 | 2.88 | 2.83 | 2.88 | 3.07 |
Pivot Point | 2.76 | 2.76 | 2.73 | 2.75 | 2.76 |
Support 1 (S1) | 2.58 | 2.64 | 2.51 | 2.56 | 2.37 |
Support 2 (S2) | 2.44 | 2.56 | 2.43 | 2.35 | |
Support 3 (S3) | 2.26 | 2.44 | 2.32 | ||
Support 4 (S4) | 2.24 |